TipRanks
TipRanksTop Financial ExpertsInsidersMichael R. Hayden

Michael R. Hayden Insider Profile

18 Followers
Michael R. Hayden, Director at AbCellera Biologics, holds 1.49M shares in AbCellera Biologics (Ticker: ABCL), holds 78.30K shares in Ionis Pharmaceuticals (Ticker: IONS), holds 0.00 shares in 89bio (Ticker: ETNB). Most recently, Michael R. Hayden Bought ― shares of AbCellera Biologics on Aug 24, 2026 for an estimated value of $570.44K.
See the Hottest Stocks Based on Insider Trading >
tipranks
Michael R. Hayden

Michael R. Hayden
AbCellera Biologics (ABCL)
Director

Ranked #6,839 out of 109,349 Corporate Insiders

Profitable Transactions

47%
7 out of 15 Profitable Transactions

Average Return

+22.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$35M
55.59%
34.51%
9.90%
A breakdown of Michael R. Hayden's holdings
See the Top Stocks by Insiders

Insider Roles

AbCellera Biologics
(ABCL)
Director
Xenon
(XENE)
Director
Ionis Pharmaceuticals
(IONS)
Director
Roles that Michael R. Hayden holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Xenon
(XENE)
Rating:Informative Buy
Date:Aug 14, 2017 - Aug 14, 2018
Return:+356.00%
The most profitable trade made by Michael R. Hayden
See the Latest Stocks Traded by Insiders

Michael R. Hayden's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ABCL
AbCellera Biologics
Aug 24, 2026
Director
Informative Buy
570.44K
$19.51M
XENE
Xenon
May 20, 2021
Director
Uninformative Buy
13.47K
$12.11M
IONS
Ionis Pharmaceuticals
Jul 31, 2026
Director
Informative Buy
1.06M
$3.48M
ETNB
89bio
Oct 30, 2025
―
Uninformative Sell
―
$0.00
List of latest transactions for each holding click on a transaction to see Michael R. Hayden's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Michael R. Hayden insider profile FAQ

What is the percentage of profitable transactions made by Michael R. Hayden?
The percentage of profitable transactions made by Michael R. Hayden is 47%.
    What is the average return per transaction made by Michael R. Hayden?
    The average return per transaction made by Michael R. Hayden is 22.50%.
      What stocks does Michael R. Hayden hold?
      Michael R. Hayden holds: ABCL, XENE, IONS, ETNB stocks.
        What was Michael R. Hayden’s latest transaction?
        Michael R. Hayden latest transaction was an Informative Buy of $570.44K.
          What was Michael R. Hayden's most profitable transaction?
          Michael R. Hayden’s most profitable transaction was an Informative Buy of XENE stock on August 14, 2017. The return on the trade was 356.00%.
            What is Michael R. Hayden's role in AbCellera Biologics?
            Michael R. Hayden's role in AbCellera Biologics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.